Parkinson's Disease Trial, Not Yet Recruiting NCT06538909 Sponsor: Tel-Aviv Sourasky Medical Center Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT06538909
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Parkinson's disease according to recognised international diagnostic guidelines, with a disease severity rating of Stage 1 to 3 (meaning the condition ranges from mild to moderate).
  • People whose walking ability is affected to at least some degree, as measured by a standard Parkinson's assessment tool (MDS-UPDRS section 3.10).
  • People who score above 15 on a standard memory and thinking assessment called the MoCA test.
  • People who have a stable heart and cardiovascular condition and are able to do light to moderate aerobic activity such as walking.
  • People who do not have bone, joint, or other physical conditions that affect the way they walk, as determined by the research team.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have moderate or severe depression, based on a score of 18 or higher on a standard depression questionnaire (BDI-II).
  • People who have bone, joint, or other physical conditions that affect the quality of their walking, as determined by the research team.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
1 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

motion capture; describe brain activity by EEG cap; describe muscles activity by EMG electrodes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov